Dysfunctional sarcomere contractility contributes to muscle weakness in ACTA1‐related nemaline myopathy (NEM3)
- 12 January 2018
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 83 (2) , 269-282
Abstract
Objective: Nemaline myopathy (NM) is one of the most common congenital nondystrophic myopathies and is characterized by muscle weakness, often from birth. Mutations in ACTA1 are a frequent cause of NM (ie, NEM3). ACTA1 encodes alpha‐actin 1, the main constituent of the sarcomeric thin filament. The mechanisms by which mutations in ACTA1 contribute to muscle weakness in NEM3 are incompletely understood. We hypothesized that sarcomeric dysfunction contributes to muscle weakness in NEM3 patients.Methods: To test this hypothesis, we performed contractility measurements in individual muscle fibers and myofibrils obtained from muscle biopsies of 14 NEM3 patients with different ACTA1 mutations. To identify the structural basis for impaired contractility, low angle X‐ray diffraction and stimulated emission‐depletion microscopy were applied.Results: Our findings reveal that muscle fibers of NEM3 patients display a reduced maximal force‐generating capacity, which is caused by dysfunctional sarcomere contractility in the majority of patients, as revealed by contractility measurements in myofibrils. Low angle X‐ray diffraction and stimulated emission‐depletion microscopy indicate that dysfunctional sarcomere contractility in NEM3 patients involves a lower number of myosin heads binding to actin during muscle activation. This lower number is not the result of reduced thin filament length. Interestingly, the calcium sensitivity of force is unaffected in some patients, but decreased in others.Interpretation: Dysfunctional sarcomere contractility is an important contributor to muscle weakness in the majority of NEM3 patients. This information is crucial for patient stratification in future clinical trials. Ann Neurol 2018;83:269–282Keywords
Funding Information
- National Institute of Child Health and Human Development (R01 HD075802)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR044345)
- Muscular Dystrophy Association (MDA383249)
- National Institute of General Medical Sciences (9 P41 GM103622)
- Swedish Research Council (2015‐00385)
This publication has 61 references indexed in Scilit:
- Combined MRI and 31P-MRS Investigations of the ACTA1(H40Y) Mouse Model of Nemaline Myopathy Show Impaired Muscle Function and Altered Energy MetabolismPLOS ONE, 2013
- Activation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseasesNature Medicine, 2012
- Changes in cross-bridge cycling underlie muscle weakness in patients with tropomyosin 3-based myopathyHuman Molecular Genetics, 2011
- Tropomyosin Position on F-Actin Revealed by EM Reconstruction and Computational ChemistryBiophysical Journal, 2011
- Dominant Mutations in KBTBD13, a Member of the BTB/Kelch Family, Cause Nemaline Myopathy with CoresThe American Journal of Human Genetics, 2010
- Altered myofilament function depresses force generation in patients with nebulin-based nemaline myopathy (NEM2)Journal of Structural Biology, 2010
- Mutations and polymorphisms of the skeletal muscle α-actin gene (ACTA1)Human Mutation, 2009
- Thin filament length dysregulation contributes to muscle weakness in nemaline myopathy patients with nebulin deficiencyHuman Molecular Genetics, 2009
- A Novel Nemaline Myopathy in the Amish Caused by a Mutation in Troponin T1The American Journal of Human Genetics, 2000
- SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modelingElectrophoresis, 1997